louisiana semaglutide ban FDA on Compounded GLP-1 Drugs: What to Know Louisiana Senate approves weight loss

Tirzepatide data comes from the SURMOUNT-1 trial with 2,539 participants over 72 weeks

The weight loss from a GLP-1 may further accelerate muscle loss and bone mass density if not paired with adequate protein intake and resistance training, per 2025 analyses showing mixed anabolic effects (4)

In a population without specific risk factors for thyroid cancer, the benefits of GLP-1 RAs will largely outweigh the harm. The European Medicines Agency in October 2023 announced that they did not find a causal link between GLP-1s and thyroid cancer after a months-long review

In that case, talk to your provider, who may recommend lowering your dose in the short-term until your body becomes acclimated again.

In essence, the drug made cocaine less stimulating on a chemical level